Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy

Eleftherios P. Mamounas, Hanna Bandos, Julia White, Thomas B. Julian, Atif J. Khan, Simona F. Shaitelman, Mylin A. Torres, Frank A. Vicini, Patricia A. Ganz, Susan A. McCloskey,

New England Journal of Medicine · 2025 · 44 citations · 24 references

DOIFull text

Open access

Abstract

The addition of adjuvant regional nodal irradiation did not decrease the risk of invasive breast cancer recurrence or death from breast cancer in patients who had negative axillary nodes after neoadjuvant chemotherapy. (Funded by the National Institutes of Health; NSABP B-51-Radiation Therapy Oncology Group 1304 ClinicalTrials.gov number, NCT01872975.).

References

24